Abstract:TIM-3 (T cell immunoglobulin and mucin-domain containing protein 3) is a member of the TIM family of proteins that is preferentially expressed on Th1 polarized CD4+ and CD8+ T cells. Recent studies indicate that TIM-3 serves as a negative regulator of T cell function (i.e. T cell dependent immune responses, proliferation, tolerance, and exhaustion). Despite having no recognizable inhibitory signaling motifs, the intracellular tail of TIM-3 is apparently indispensable for function. Specifically, the conserved residues Y265/Y272 and surrounding amino acids appear to be critical for function. Mechanistically, several studies suggest that TIM-3 can associate with interleukin inducible T cell kinase (ITK), the Src kinases Fyn and Lck, and the p85 phosphatidylinositol 3-kinase (PI3K) adaptor protein to positively or negatively regulate IL-2 production via NF-κB/NFAT signaling pathways. To begin to address this discrepancy, we examined the effect of TIM-3 in two model systems. First, we generated several Jurkat T cell lines stably expressing human TIM-3 or murine CD28-ECD/human TIM-3 intracellular tail chimeras and examined the effects that TIM-3 exerts on T cell Receptor (TCR)-mediated activation, cytokine secretion, promoter activity, and protein kinase association. In this model, our results demonstrate that TIM-3 inhibits several TCR-mediated phenotypes: i) NF-kB/NFAT activation, ii) CD69 expression, and iii) suppression of IL-2 secretion. To confirm our Jurkat cell observations we developed a primary human CD8+ cell system that expresses endogenous levels of TIM-3. Upon TCR ligation, we observed the loss of NFAT reporter activity and IL-2 secretion, and identified the association of Src kinase Lck, and PLC-γ with TIM-3. Taken together, our results support the conclusion that TIM-3 is a negative regulator of TCR-function by attenuating activation signals mediated by CD3/CD28 co-stimulation.

Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9

The glycoimmune checkpoint receptor Siglec-7 interacts with T-cell ligands and regulates T-cell activation

Modulation of Siglec-7 Signaling Via In Situ-Created High-Affinity cis -Ligands

Suppressing Immune Responses Using Siglec Ligand-Decorated Anti-receptor Antibodies

Siglec-mediated regulation of immune cell function in disease

Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in Cancer

Broad and Direct Interaction Between TLR and Siglec Families of Pattern Recognition Receptors and Its Regulation by Neu1.

SIGIRR, a Negative Regulator of Toll-like Receptor–interleukin 1 Receptor Signaling

CMIP is a negative regulator of T cell signaling

T Cell Receptor-Independent Basal Signaling via Erk and Abl Kinases Suppresses RAG Gene Expression

TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway

Regulatory T Cells Require TCR Signaling for Their Suppressive Function.

Signaling Through Tlr7 Enhances The Immunosuppressive Activity Of Murine Cd4(+)Cd25(+) T Regulatory Cells

SIGIRR / TIR8: A Negative Regulator of Toll-IL-1R Signaling

Induction and transcriptional regulation of the co-inhibitory gene module in T cells

VSIG4/CRIg directly regulates early CD8+ T cell activation through its counter-receptor in a narrow window

Opposing Effect of IFNγ and IFNα on Expression of NKG2 Receptors: Negative Regulation of IFNγ on NK Cells

IL-7 Receptor Signals Inhibit Expression of Transcription Factors TCF-1, LEF-1, and RORγt

TLR10 Is a Negative Regulator of Both MyD88-Dependent and -Independent TLR Signaling

Siglec‐G Suppresses CD8+ T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy

A Lysosomal Protein Negatively Regulates Surface T Cell Antigen Receptor Expression by Promoting Cd3 Zeta-Chain Degradation